Evaluates an optimized bacterial agent’s effectiveness against soybean sclerotiniosis, suggesting a sustainable alternative to fungicides.
BACKGROUND Sclerotinia sclerotiorum causes severe yield losses in soybean. Overuse of chemical fungicides leads to pollution, residues, and resistance. Biological control offers a sustainable alternative. This study optimized fermentation of Serratia marcescens G4, developed microcapsules (G4Ms), and evaluated their efficacy against soybean sclerotiniosis. RESULTS Under initial culture conditions, the OD 600 of strain G4 reached 2.241 after 12 h. Sucrose and soybean peptone were identified as the most effective carbon and nitrogen sources, respectively. Response surface optimization determined the optimal medium as sucrose 13.21 g L −1 , soybean peptone 10.33 g L −1 , yeast extract 10.95 g L −1 , and NaCl 10 g L −1 , under which the predicted OD 600 increased to 2.474 (10.4% improvement). The optimal culture conditions were 35 °C, pH 7.0, 3% (v/v) inoculum, 155 rpm, and 50 mL working volume. Microcapsules prepared with 80% maltodextrin (G4Ms) exhibited enhanced storage stability, stronger biofilm formation, and improved inhibitory activity compared to free‐living G4 cells. In pot experiments, G4Ms achieved a control efficacy of 55.84% against soybean sclerotiniosis, and their application increased soil enzyme activities and microbial diversity. CONCLUSION G4Ms is an effective, stable, and soil‐friendly biocontrol agent against S. sclerotiorum ‐induced soybean sclerotiniosis, highlighting its potential as a sustainable alternative to chemical fungicides for integrated disease management.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: